Press Releases (-) Any 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2011 November 29, 2011 arGEN-X is awarded €1.3 million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform for Addressing Challenging Disease Targets September 6, 2011 arGEN-X presents significant progress at Biopharm America 2011 July 25, 2011 arGEN-X announces non-exclusive license with BioWa for Potelligent® technology May 15, 2011 arGEN-X initiates a second pre-clinical development program in under 18 months from start of operations January 4, 2011 arGEN-X signs discovery and development alliance with Lilly 2010 November 4, 2010 arGEN-X appoints Dr Debbie Allen as Senior Director Business Development September 26, 2010 arGEN-X awarded €1.5 million iwt grant to accelerate pre-clinical antibody development July 7, 2010 arGEN-X granted broad patent covering its unique simple antibody™ platform April 19, 2010 arGEN-X concludes EUR 12.5 million Series A financing round February 28, 2010 arGEN-X simple antibody™ platform set to transform therapeutic antibody discovery & development 2009 November 9, 2009 arGEN-X opens new R&D facility in Flanders September 9, 2009 arGEN-X raises €9.5 million to put SIMPLE Antibody™ platform to work Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Current page 29
